^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Prostadiag®

    Company:
    OncoDiag
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Prostadiag® is an accurate tissue-based test to predict non-evolutive localized prostate cancer (LPCa). It uses next generation sequencing (NGS) technology for gene expression analysis.
    Cancer:
    Prostate Cancer
    Gene:
    PCA3 (Prostate cancer associated 3)
    Method:
    Next-Generation Sequencing (NGS)